The United States Patent and Trademark Office (USPTO) has issued US Patent 9,753,036 to EDP Biotech Corp, Knoxville, Tenn, covering methods and compositions for the screening and detection of colorectal cancer. The company’s first US patent, the milestone puts EDP Biotech in position to finalize development and commercialization of ColoMarker,…
Source: CLP
Read more: EDP Biotech Receives Patent for Colorectal Cancer Detection Method